Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Working Capital/Sales

    Back to All Ratios
BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.181.491.371.031.28

What is the latest Working Capital/Sales ratio of BLISS GVS PHARMA ?

The latest Working Capital/Sales ratio of BLISS GVS PHARMA is 1.18 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.18
Mar20231.49
Mar20221.37
Mar20211.03
Mar20201.28

How is Working Capital/Sales of BLISS GVS PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.18
-20.81
Mar2023 1.49
8.76
Mar2022 1.37
33.01
Mar2021 1.03
-19.53
Mar2020 1.28 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Working Capital/Sales ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,693.2 Cr 0.6% 26.7% 15.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,892.0 Cr 3.7% -3.2% 46.6% Stock Analytics
DIVIS LABORATORIES ₹166,129.0 Cr 5.1% 6.1% 64% Stock Analytics
CIPLA ₹121,231.0 Cr 0.6% -3.7% 26.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,431.0 Cr 1.9% -3.4% 5.8% Stock Analytics
ZYDUS LIFESCIENCES ₹97,639.9 Cr 2.3% -3.4% 54% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

0.6%

26.7%

15.8%

SENSEX

0.9%

2%

21%


You may also like the below Video Courses